FENC
Fennec Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.35
−3.27%Forward multiples
Based on analyst estimates
- P/E forward
- 15.31x
- P/E 2026E
- 37.04x
- P/E 2027E
- 11.66x
- P/E 2028E
- 7.17x
- P/S forward
- 3.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.55x
- Price / sales
- 6.13x
- Price / cash flow
- -177.91x
Enterprise value
- Enterprise value
- $321.7M
- EV / sales
- 5.43x
- EV / EBITDA
- -135.34x
- EV / EBIT
- -276.61x
- Market cap
- $362.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026